Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States
- 31 January 2005
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 52 (1), 27-31
- https://doi.org/10.1016/j.jaad.2004.08.004
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- How Robust Are Health Plan Quality Indicators to Data Loss? A Monte Carlo Simulation Study of Pediatric Asthma TreatmentHealth Services Research, 2003
- AAD consensus statement on psoriasis therapiesJournal of the American Academy of Dermatology, 2003
- Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and costExpert Opinion on Pharmacotherapy, 2003
- Stigmatization and psoriasisBritish Journal of Dermatology, 2003
- Treatment of psoriasis. Part 2. Systemic therapiesJournal of the American Academy of Dermatology, 2001
- The cost of psoriasis treatmentJournal of the European Academy of Dermatology and Venereology, 2001
- The depression, anxiety, life satisfaction and affective expression levels in psoriasis patientsJournal of the European Academy of Dermatology and Venereology, 2000
- Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary diseaseClinical Therapeutics, 2000
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Intermittent Corticosteroid Maintenance Treatment of Psoriasis: A Double-Blind Multicenter Trial of Augmented Betamethasone Dipropionate Ointment in a Pulse Dose Treatment RegimenDermatology, 1991